1. Doppler‐derived pulmonary pulse transit time measurements in chronic obstructive pulmonary disease: Reproducibility and cardiopulmonary function.
- Author
-
Löffler, Friederike, Westhoff‐Bleck, Mechthild, Welte, Tobias, Park, Da‐Hee, Olsson, Karen M, Behrendt, Lea, Klimeš, Filip, Bauersachs, Johann, Wacker, Frank, and Pöhler, Gesa Helen
- Subjects
LUNG physiology ,HEART physiology ,PULMONARY vein physiology ,PULMONARY function tests ,LEFT heart ventricle ,STATISTICAL correlation ,DOPPLER ultrasonography ,LEFT heart atrium ,VITAL capacity (Respiration) ,HEART rate monitoring ,HEMODYNAMICS ,ELECTROCARDIOGRAPHY ,OBSTRUCTIVE lung diseases ,BLOOD flow measurement ,INTRACLASS correlation ,FORCED expiratory volume ,RESEARCH ,PULSE wave analysis ,RIGHT heart ventricle ,ECHOCARDIOGRAPHY ,EVALUATION - Abstract
Introduction: Doppler‐derived pulmonary pulse transit time (pPTT) is an auspicious hemodynamic marker in chronic pulmonary diseases. The aim is to compare four distinct pPTT measurements and its relation to right cardiac and pulmonary function. Methods: Prospectively, 25 chronic obstructive pulmonary disease (COPD) patients (four patients excluded) and 32 healthy subjects underwent repeated distinct pPTT measurements, standard echocardiography, and pulmonary function testing on the same day. pPTT was defined as the interval from the R or Q‐wave in the electrocardiogram to the corresponding pulse wave Doppler peak late systolic (S) 2 or diastolic (D) pulmonary vein flow velocity (pPTT R‐S, Q‐S, R‐D, Q‐D). Reproducibility was assessed using Bland–Altman analysis, coefficient of variation (COV), intraclass correlation coefficient (ICC), and power calculations. Associations with right ventricular RV tissue and pulse wave Doppler velocities (RV E', RV S', RV A', RV E, RV A, RV E/E', RV E/A), TAPSE, right ventricular fractional area change, left ventricular systolic and diastolic function (LV ejection fraction, E, A, E/A, E/E', septal E', lateral E'), LA diameters, as well as forced expiratory volume in 1 s, forced vital capacity (FVC) predicted (%), and in liters were analyzed. Results: There was no significant difference and no bias between pPTT measures (p range:.1–.9). COV was in COPD 1.2%–2.3%, in healthy subjects 1.0%–3.1%. ICC ranged from.92 (COPD) to.96 (healthy subjects). In COPD significant correlations were found for pPTT R‐S, Q‐S and R‐D with RV E', (all > ρ:.49, < p =.0364), pPTT R‐S, Q‐S with RV E/E' (both > ρ:.49, < p =.0291), pPTT Q‐S with RV S´ (ρ:.58, p =.0134), RV A (ρ:.59, p =.0339) and heart rate > ρ: −.39, < p =.0297). pPTT R‐S, R‐D showed significant correlations with FVC predicted (%) (ρ:.48 p =.0224) and FVC (l) (ρ:.47 p =.0347). Conclusions: All pPTT measures exhibited high reproducibility. In COPD patients pPTT measures correlate with diastolic right ventricular function. Defining Q as starting point seems clinically advantageous considering electromechanical desynchrony in patients with conduction disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF